0 Cases of Ebola confirmed in Uganda
The Ministry of Health and WHO have reported the first case of Ebola confirmed in Uganda during the outbreak in neighbouring Democratic Republic of the Congo.
Browsing: Disease Area > Viral
1 Quality control in HIV point-of-care testing – an interview with David Padley
In this interview we speak to David Padley from the National Institute for Biological Standards and Control about his recent poster ‘Point-of-Care testing for HIV: specialist quality control materials are a necessity’, presented at ECCMID 2019.
0 Zika: American subtype revealed to have the highest virulence activity in mice
Researchers from the Japanese National Institute of Infectious Disease have identified the American subtype of Zika as the most virulent for each of the contributing characteristics tested, when compared with Pacific and Southeast Asian subtypes.
0 FDA rejects Nabriva’s antibiotic Contepo for complicated UTIs: May’s industry headlines
Take a look at this month’s industry headlines including US FDA approvals for Mavyret (hepatitis C) and Dengvaxia, a rejection for Contepo and profits for Gilead Sciences.
0 Understanding human papillomaviruses using organotypic 3D models – an interview with Sally Roberts
We spoke to Sally Roberts (University of Birmingham, UK) at the recent Microbiology Society Conference (8–11 April, Belfast, UK) about her lab’s models for studying HPV and the virus–host interactions that have been uncovered as a result of this.
0 Early antiretroviral treatment could help develop long-term immune memory
Early antiretroviral treatment in people with HIV infection could allow the generation of more functional and persistent CD8 T cell responses. The results, which suggest a long-term immune memory, could have implications for HIV vaccine development.
0 Emerging technologies to investigate coronavirus emergence – an interview with Vineet Menachery
In this interview we speak to Vineet Menachery about his recent talk at the Microbiology Society’s Annual Conference (8–11 April, Belfast, UK) suggesting that CoV emergence is more complicated than receptor binding alone.
0 Slow-release delivery strategies provide better immunity for HIV vaccine
Delivering HIV vaccines via slow-release methods has enhanced the protective immune response in preclinical models, according to new research.
0 A peek behind the paper – Connor Bamford on hepatitis C and comparative genomics
Take a look behind the scenes of a recent Future Virology review, entitled: ‘Comparative host genomics: Has recent human evolution affected our immune defense against hepatitis C virus?’, as we ask the authors about the importance of the IFNL4 gene and the work that’s still to be done in the field.
0 Who should take the lead in prescribing PrEP?
Healthcare practitioners have split opinions on whether primary care doctors or other providers should take the lead on prescribing PrEP for HIV prevention, according to new research.
